Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma

被引：54

作者：

Dummer, R ^{[1
]}

Panizzon, R ^{[1
]}

Bloch, PH ^{[1
]}

Burg, G ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland

来源：

DERMATOLOGY | 2005年 / 210卷 / 01期

关键词：

cutaneous melanoma; Swiss melanoma guidelines;

D O I：

10.1159/000081482

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Melanoma is the most common lethal cutaneous neoplasm. In order to harmonize treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland have been inaugurated in 2001. These have been approved by all Swiss medical societies involved in the care of melanoma patients. New data necessitated changes concerning the safety margins (reduction to maximally 2 cm) and modifications of the recommendations of follow-up. Copyright (C) 2005 S. Karger AG, Basel.

引用

页码：39 / 44

页数：6

共 29 条

[21] High-dose interferon alfa-2b does mot diminish antibody response to GM2 vaccination in patients with resected melanoma: Results of the multicenter Eastern Cooperative Oncology Group phase II trial E2696
Kirkwood, JM
Ibrahim, J
Lowson, DH
Aikins, MB
Agarwala, SS
Collins, K
Mascari, R
Morrissey, DM
Chapman, PB
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1430 - 1436
[22] Final results of the EORTC 18871/DKG 80-1 randomised phase III trial:: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis
Kleeberg, UR
Suciu, S
Bröcker, EB
Ruiter, DJ
Chartier, C
Liénard, D
Marsden, J
Schadendorf, D
Eggermont, AMM
[J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 390 - 402
[23] LEJEUNE F, 1994, CIRC SHOCK, V43, P191
[24] Interferon alfa therapy for malignant melanoma: A systematic review of randomized controlled trials
Lens, MB
Dawes, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1818 - 1825
[25] MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
[26] POSITION PAPER OF THE MELANOMA COMMITTEE OF THE GERMAN-DERMATOLOGICAL-SOCIETY ON CUTANEOUS MALIGNANT-MELANOMA, WITH RECOMMENDATIONS FOR DIAGNOSTIC, TREATMENT AND FOLLOW-UP - STATUS 1993/94
ORFANOS, CE
JUNG, EG
RASSNER, G
WOLFF, HH
GARBE, C
[J]. HAUTARZT, 1994, 45 (05): : 285 - 291
[27] Panizzon R G, 1999, Ther Umsch, V56, P302, DOI 10.1024/0040-5930.56.6.302
[28] POO HW, 1999, CANCER, V86, P2252
[29] Cost-effectiveness of whole-body PET imaging in non-small cell lung cancer and malignant melanoma
von Schulthess, GK
Steinert, HC
Dummer, R
Weder, W
[J]. ACADEMIC RADIOLOGY, 1998, 5 : S300 - S302

← 1 2 3 →